EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy

Calogero Cipolla iD, Vittorio Gebbia, Eleonora D'Agati, Martina Greco, Chiara Mesi iD, Giuseppa Scandurra iD, Maria Rosaria Valerio

Cancers · 30.09.2024 · 16 (19) · 3354

DOI: 10.3390/cancers16193354 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cancers, online erschienen am 30.09.2024. Verfasst von Calogero Cipolla und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, 90100 Palermo, Italy. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

In breast cancer (BC) patients, axillary management has undergone major improvements over the last few years, and efforts to identify the optimal strategy for the management of axillary surgery are still ongoing.

Methods

In current clinical practice, women with clinically node-positive (cN+) BC usually receive neoadjuvant chemotherapy (NACT) with the aim of reducing the extent of primary disease and, thus, allowing for axillary-conservative surgery. Remarkably, after NACT, up to one out of three patients achieves an axillary pathologic complete response, which, in turn, is associated with a more favorable prognosis than residual axillary disease. However, NACT is not without drawbacks, as NACT-associated inflammation can damage lymphatic vessels. Furthermore, varying degrees of response may occur in the axillary lymph nodes, increasing the false negative rate for sentinel biopsy.

Results

At present, there is no consensus on the optimal approach in patients with cN+ BC undergoing NACT, although multidisciplinary management seems to be recommended.

Conclusions

This narrative review provides a comprehensive overview of axillary management in cN+ BC patients undergoing NACT. It uses a multidisciplinary approach that encompasses the oncological management perspectives, as well as surgical and chemotherapeutic viewpoints.

Schlagwörter

Stichwörter der Autor:innen

breast cancermultidisciplinary managementneoadjuvant chemotherapynode-positive disease

Autor:innen und Institutionen

  • Department of Precision Medicine in Medical, Surgical and Critical Care (Me.Pre.C.C.), University of Palermo, 90100 Palermo, Italy.
  • Breast Unit, AOUP Policlinico Paolo Giaccone, 90100 Palermo, Italy.
  • Department of Medicine and Surgery, Kore University of Enna, 94100 Enna, Italy.
  • Medical Oncology Unit, Cdc Torina, 90100 Palermo, Italy.
  • Medical Oncology Unit, AOUP Policlinico Paolo Giaccone, 90100 Palermo, Italy.
  • Medical Oncology Unit, Ospedale Cannizzaro, 95126 Catania, Italy.

ORCID-Profile: Calogero Cipolla, Chiara Mesi, Giuseppa Scandurra

Zitieren

APA

Cipolla, C., Gebbia, V., D'Agati, E., Greco, M., Mesi, C., Scandurra, G., & Valerio, M. R. (2024). Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy. Cancers, 16(19), 3354. https://doi.org/10.3390/cancers16193354

Vancouver

Cipolla C, Gebbia V, D'Agati E, Greco M, Mesi C, Scandurra G, et al. Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy. Cancers. 2024;16(19):3354. doi:10.3390/cancers16193354

BibTeX
@article{Cipolla2024,
  author = {Cipolla, Calogero and Gebbia, Vittorio and D'Agati, Eleonora and Greco, Martina and Mesi, Chiara and Scandurra, Giuseppa and Valerio, Maria Rosaria},
  title = {Comprehensive Axillary Management of Clinically Node-Positive (cN+) Breast Cancer Patients: A Narrative Review on Neoadjuvant Chemotherapy},
  journal = {Cancers},
  year = {2024},
  volume = {16},
  number = {19},
  pages = {3354},
  doi = {10.3390/cancers16193354}
}
Kostenlos starten →